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Abstract: Kindlin-3 is a member of the kindlin family of focal adhesion proteins which bind to integrin beta-chain 
cytoplasmic domains to regulate integrin function. In contrast to kindlin-1 and kindlin-2 proteins, kindlin-3 is ex-
pressed mainly in the hematopoietic system. Mutations in kindlin-3 result in the rare genetic disorder, leukocyte 
adhesion deficiency type III (LAD-III), which is characterized by bleeding and recurrent infections due to deficient 
beta1, beta2 and beta3 integrin activation in platelets and leukocytes. Here, we review the role of kindlin-3 in inte-
grin activation and in different immune cell functions.
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Introduction
Integrins of the beta2-family (alphaLbeta2; 
CD11a/CD18; LFA-1, alphaMbeta2; CD11b/
CD18; Mac-1, alphaXbeta2; CD11c/CD18 and 
alphaDbeta2; CD11d/CD18 integrins) play a 
vital role in leukocyte adhesion and migration 
in vivo. These receptors are exclusively 
expressed on leukocytes and bind to ligands 
such as intercellular adhesion molecules 
(ICAMs) on other leukocytes and endothelial 
cells, as well as soluble proteins such as the 
complement protein iC3b. beta2-integrins are 
essential for the firm adhesion of leukocytes to 
endothelial cells in the blood vessels during 
shear flow conditions [1]. They have also been 
reported to be important for neutrophil activa-
tion, T cell-dendritic cell contact formation and 
T cell killing of target cells. In addition, alphaM-
beta2 and alphaXbeta2-integrins are important 
receptors for complement (iC3b) and mediate 
phagocytosis of complement-coated particles. 
A low or absent expression of beta2-integrins 
causes leukocyte adhesion deficiency type I 
(LAD-I), a rare genetic condition where leuko-
cytes (especially neutrophils) cannot exit the 
blood stream, resulting in recurrent bacterial 
infections and fungal infections and delayed 
would healing, showing the crucial importance 
of these receptors in immunity [2].
Leukocytes also express other integrins, such 
as alpha4beta1-integrin (VLA-4), which plays 
important roles in lymphocyte trafficking 
through binding to ligands such as vascular cell 
adhesion molecule-1 (VCAM-1).
The alphaIIbbeta3 integrin is expressed on 
platelets and binds to ligands such as fibronec-
tin, fibrinogen, von Willebrandt factor and 
thrombospondin. This integrin is important for 
platelet aggregation, and deficiencies in the 
function of this receptor are associated with 
Glanzmann thrombasthenia, a bleeding disor-
der [3].
Kindlin-3 binds integrin beta-chain cytoplas-
mic domains and regulates integrin function
Integrins are regulated by the binding of cyto-
plasmic factors, such as talin, filamin, 14-3-3 
proteins and kindlin to their intracellular tails, 
and these interactions are of crucial impor-
tance for integrin function [1, 4, 5]. 
The kindlin family of focal adhesion proteins 
consists of three members. Kindlin-1 is 
expressed mainly in epithelial cells and kerati-
nocytes, and mutations in kindlin-1 lead to skin 
blistering, skin atrophy and periodontal disease 
in patients with Kindler Syndrome [6]. Kindlin-2 
is ubiquitously expressed and kindlin-2 knock-
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out mice are embryonic lethal at the preimplan-
tation stage [7]. Kindlin-2 is necessary for myo-
genesis and myocyte elongation [8, 9], and 
mice with kindlin-2 deficiency (kindlin-2 +/- ani-
mals) display defective angiogenesis and a 
leaky and immature vasculature [10]. 
In contrast to kindlin-1 and kindlin-2, kindlin-3 
is expressed mainly in hematopoietic cells [11], 
although expression in endothelial cells has 
also been described [12]. Kindlin-3 contains a 
FERM domain and a PH-domain and adopts an 
elongated conformation which is similar to that 
of talin’s head domain [13] (Figure 1). 
Recently, it was discovered that kindlin-3 is 
mutated in the rare genetic disorder, leukocyte 
adhesion deficiency type III (LAD-III). Like LAD-I 
patients, LAD-III patients suffer from recurrent 
infections, but in addition, the patients have a 
bleeding phenotype due to deficient platelet 
integrin activation [14-16]. In addition, the 
patients may suffer from osteopetrosis [15], 
due to deficient integrin-mediated osteoclast 
bone resorption [17]. Kindlin-3 binds to beta1, 
beta2 and beta3 integrin cytoplasmic domains 
and regulates integrin functions in vivo. The 
kindlin binding site in the integrin beta2-chain 
consists of the membrane-distal NPXY-motif [5] 
and a TTT-domain in the beta2-integrin tail [13, 
18]. The kindlin binding site does not overlap 
with the binding site for talin, another impor-
tant integrin regulator which binds to the mem-
brane-proximal NPXY-motif [5, 18]. However, 
the kindlin-3 binding site does overlap with 
binding sites for other integrin interactors, eg 
filamin, a negative regulator of integrins [4] and 
14-3-3 proteins, which bind to phosphorylated 
beta2-integrins and appears to regulate Rac-1 
signalling and cell spreading downstream of the 
integrin [4, 19, 20]. In addition, sorting nexin 
17, a protein which regulates integrin recycling 
has been reported to bind to a similar site in 
beta1-integrins [21]. Whether there is competi-
tion between these proteins for the binding site 
in beta2-integrins, and what the functional con-
sequences of such competition would be is 
unknown at present. 
Figure 1. Schematic diagram of kindlin-3 functions in cells. The integrin binding site is in the F3 subdomain of 
kindlin-3.
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Kindlin-3 knockout animals die early after birth 
due to severe bleeding because of a deficiency 
in alphaIIbbeta3 integrin activation and platelet 
aggregation [22]. Study of kindlin-3 deficient 
neutrophils have revealed an essential role for 
kindlin-3 in the regulation of neutrophil adhe-
sion to endothelial cells under shear flow in vivo 
[5], and studies of other (human and mouse) 
immune cell types has revealed a similar role 
for kindlin-3 in other leukocytes, such as B cells 
[23], CD4 T cells and effector T cells [18, 24, 
25] and NK cells [26] (Figure 1). 
Because kindlin-3 knockout animals die early 
after birth due to the bleeding phenotype, and 
because lymphocyte development is affected 
in these animals [5], it has remained unclear 
how kindlin-3 regulates beta2-integrins in lym-
phocytes in vivo. The development of a novel 
animal model, where the kindlin-3 binding site 
in the beta2-integrin has been mutated (TTT/
AAA-beta2-integrin knock-in mouse model), 
has confirmed the importance of kindlin-3 in 
regulation of leukocyte adhesion in vivo, as 
these animals display splenomegaly and neu-
trophilia [18]. Lymphocyte development is nor-
mal in these mice, but kindlin-3 binding to the 
beta2-integrin cytoplasmic domain is essential 
for chemokine-induced CD4+ T cell adhesion to 
ICAM-1 and endothelial cells under shear flow 
conditions and for normal lymphocyte recircula-
tion and homing to lymph nodes. In addition, 
the integrin-kindlin interaction is necessary for 
effector T cell adhesion under flow conditions 
[18].
Kindlin-3 is not necessary for all integrin-medi-
ated functions in the immune system
Clues to how kindlin-3 regulates integrins have 
come from detailed investigations of integrin 
function in kindlin-3 deficient cells or cells 
where the interaction between kindlin-3 and 
the integrin has been abolished. Neutrophils 
deficient in talin are deficient in both rolling and 
arrest, whilst kindlin deficient neutrophils can 
still mediate slow rolling [27], indicating that 
these different integrin regulators serve differ-
ent roles in integrin activation (Table 1). Neither 
talin nor kindlin-3 deficient neutrophils were 
able to adopt the high-affinity conformation 
(extended/open I domain) of the LFA-1 integrin, 
whilst only talin -/- cells were deficient the first 
step of integrin activation to the intermediate 
affinity form (extended/closed I domain) [27].
We have recently shown that the integrin/kind-
lin interaction is not completely necessary for 
integrin-mediated effector T cell 2-dimensional 
migration on ICAM-1, or for beta2-integrin medi-
ated rolling on ICAM-1 under shear flow condi-
tions [18]. Atomic force microscopy measure-
ments of early interactions between the integ-
rin and its ligand have revealed that such early 
interactions in the absence of shear flow is nor-
mal [18]. Probably because of this, integrin-
kindlin interactions is not essential for T cell 
activation in the spleen in vivo, which occurs in 
an environment without shear stress [18]. In 
contrast, talin is necessary for T cell activation 
in vivo [28]. In addition, recent studies have 
shown that kindlin-3 is not necessary for effec-
tor T cell diapedesis [25]. Interestingly, it is also 
not necessary for the induction of experimental 
autoimmune encephalomyelitis in mice, alth- 
ough it is necessary for recruitment of autore-
active effector T cells into the naïve CNS [24]. 
These different requirements for kindlin-3 in 
integrin regulation in effector T cells appear to 
reflect differences in ligand levels on resting 
and inflamed endothelium; kindlin-3 appears to 
be required only for adhesion to low, but not 
high, levels of integrin ligands ICAM-1 and 
VCAM-1. Collectively, these studies reveal the 
selective role of the integrin/kindlin interac-
tions in regulating integrin-mediated adhesive 
functions (Table 1).
Outside-in signaling
In addition to its role in integrin activation to 
mediate adhesion under shear flow conditions, 
Table 1. Comparison of talin and kindlin-3 functions in integrin regulation and the immune system
Talin -/- Kindlin-3 -/- References
Integrin conformation Low affinity conformation only Low and intermediate affinity conformations [27]
Integrin outside-in signalling Impaired Impaired [17]
Lymphocyte development ? (embryonic lethal) Impaired [5, 35]
Leukocyte rolling under shear flow Impaired Normal [18, 27]
Leukocyte firm adhesion/spreading Impaired Impaired [5, 18, 28]
T cell activation (spleen) Impaired Normal [18, 28]
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Kindlin-3 is thought to be involved in integrin 
outside-in signaling [29]. Integrin-mediated cell 
spreading is deficient in kindlin-3 -/- neutrophils 
[5] and in effector T cells where the kindlin-3 
binding site is mutated in the beta2-integrin 
[18]. In addition, integrin-mediated outside-in 
signaling through Syk, Erk and Akt is deficient in 
kindlin-3 -/- osteoclasts [17], and targeted 
knockdown of kindlin-3 leads to reduced 
alphaMbeta2 (Mac-1)-mediated Syk and Vav 
signaling, and reduced Rac-1 activation in Mac-
1-transfected K562 cells [30]. How kindlin-3 
couples to these intracellular signaling path-
ways remains to be investigated in the future.
Non-integrin related effects of kindlin defi-
ciency
In addition to integrins, kindlin proteins have 
also been described to interact with binding 
partners such as integrin linked kinase (ILK) 
and migfilin and kindlin-3 has been described 
to interact with receptor for activated C kinase 
1 (RACK1) [29, 31]. Interestingly, kindlin-3 defi-
cient mice have been described to have abnor-
mally shaped erythrocytes with disrupted mem-
brane skeletons [32]. As erythrocytes don’t 
have integrins, this finding indicates that kind-
lin-3 has functions in cells which are not integ-
rin dependent. The molecular targets for such 
functions of kindlin-3 have so far not been 
described. 
Integrin-independent functions have also been 
described for other kindlin-family members. 
Kindlin-2 binds directly to the clathrin heavy 
chain, which regulates clathrin-dependent vesi-
cle trafficking in endothelial cells in an integrin-
independent manner. Therefore, trafficking of 
CD39 and CD73, which are enzymes involved in 
ADP/AMP catabolism, is affected in Kindlin2 +/- 
mice [33]. Kindlin-2 has also been reported to 
bind to the TGF-β type 1 receptor through its 
FERM domain and to Smad3 through its N ter-
minus, which mediates this interaction in 
human kidney tubular epithelial cells [34]. 
Kindlin-1 and kindlin-2 have also been des- 
cribed to be found in the nucleus of cells; no 
such localization of kindlin-3 has so far been 
reported [6]. 
Conclusions
It is by now well established that kindlin-3 plays 
a fundamentally important role in integrin regu-
lation in immune cells. Further research is now 
necessary to reveal the molecular details of 
this process, as well as defining non-integrin 
related protein partners for kindlin-3.
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